Works matching IS 11782595 AND DT 2020 AND VI 34 AND IP 4
Results: 9
Patent Cliffs in the Era of Complex Therapies and Biologics.
- Published in:
- Pharmaceutical Medicine, 2020, v. 34, n. 4, p. 271, doi. 10.1007/s40290-020-00348-7
- By:
- Publication type:
- Article
Major Pharmaceutical Conferences and Courses: October 2020 to November 2020.
- Published in:
- Pharmaceutical Medicine, 2020, v. 34, n. 4, p. 291, doi. 10.1007/s40290-020-00347-8
- Publication type:
- Article
Forum.
- Published in:
- Pharmaceutical Medicine, 2020, v. 34, n. 4, p. 279, doi. 10.1007/s40290-020-00346-9
- Publication type:
- Article
Using Data from the Canadian Post-marketing Spontaneous Pharmacovigilance System for Drug Safety Research: A Feasibility Study.
- Published in:
- Pharmaceutical Medicine, 2020, v. 34, n. 4, p. 263, doi. 10.1007/s40290-020-00345-w
- By:
- Publication type:
- Article
Correction to: Providing Patients with Critical or Life-Threatening Illnesses Access to Experimental Drug Therapy: A Guide to Clinical Trials and the US FDA Expanded Access Program.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
The NIMH 'Fast-Fail Trials' (FAST) Initiative: Rationale, Promise, and Progress.
- Published in:
- Pharmaceutical Medicine, 2020, v. 34, n. 4, p. 233, doi. 10.1007/s40290-020-00343-y
- By:
- Publication type:
- Article
IL-6 Inhibitors in the Treatment of Serious COVID-19: A Promising Therapy?
- Published in:
- Pharmaceutical Medicine, 2020, v. 34, n. 4, p. 223, doi. 10.1007/s40290-020-00342-z
- By:
- Publication type:
- Article
Evolving Communication with Healthcare Professionals in the Pharmaceutical Space: Current Trends and Future Perspectives.
- Published in:
- Pharmaceutical Medicine, 2020, v. 34, n. 4, p. 247, doi. 10.1007/s40290-020-00341-0
- By:
- Publication type:
- Article
Is Psoriasis Treatment a Risk Factor for Inflammatory Bowel Disease?
- Published in:
- Pharmaceutical Medicine, 2020, v. 34, n. 4, p. 257, doi. 10.1007/s40290-020-00340-1
- By:
- Publication type:
- Article